Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
PHINIA reported third quarter 2026 net sales of $912 million, a 0.4% increase year-over-year, and net earnings of $67 million. The company updated its full-year 2026 guidance and returned $76 million to shareholders through buybacks and dividends during the quarter.
“Our third quarter results were consistent with our expectations and reflect stable end market demand, continued aftermarket momentum, and strong financial discipline.”
Brady Ericson, President and Chief Executive Officer of PHINIA
“We generated another quarter of profitable growth, with Adjusted EBITDA increasing $2 million, or 20 bps, despite higher R&D spending and investments in customer relationships, demonstrating the resilience of our business and consistent execution.”
Brady Ericson, President and Chief Executive Officer of PHINIA
Bandwidth Inc. reported a significant increase in cash and cash equivalents to $171.3 million as of September 30, 2026, compared to $102.8 million at the end of 2025. The company's total assets grew to $1.09 billion, while its accumulated deficit decreased from $84.3 million to $72.6 million, indicating positive net income for the nine-month period.
Cheniere Energy Partners reported Q3 2026 revenue of $2.57 billion and net income of $639 million, driven by higher LNG margins and volumes. The partnership tightened its full-year 2026 distribution guidance to $3.30 - $3.40 per unit and highlighted a new long-term SPA with QatarEnergy for up to 2 mtpa of LNG.
Cheniere Energy reported Q3 2026 revenues of $6.17 billion and net income of $1.17 billion, significantly raising its full-year 2026 Consolidated Adjusted EBITDA guidance to a range of $8.75 billion - $9.25 billion. The company also increased its quarterly dividend by over 12% to $0.625 per share and announced long-term LNG sale and purchase agreements with QatarEnergy and Petrobras.
Intercontinental Exchange (ICE) reported record third-quarter 2026 results with net revenues of $2.8 billion, a 15% increase year-over-year. The company achieved GAAP diluted EPS of $1.67 and adjusted diluted EPS of $2.02, both up 18% from the prior year, driven by strong performance across its exchange and data segments.
Term
Q3 2026
“We're pleased to report the best third quarter in ICE's history, with revenues, operating income and earnings per share each growing by double digits. Our customers come to ICE to manage risk, to connect with one another, to access our data and to run critical parts of their business on our platforms.”
Jeff Sprecher, ICE Chair & Chief Executive Officer
“Through the first nine months of the year, we've delivered record revenues, adjusted operating income and adjusted earnings per share, underscoring the strength and durability of our business model.”
Arxis, Inc. reported a significant turnaround for the nine months ended September 30, 2026, with net income of $132.1 million compared to a net loss of $43.7 million in the prior year. The company completed its initial public offering and a corporate reorganization in April 2026, resulting in a substantial increase in total stockholders' equity to $5.35 billion.
LKQ Corporation reported third quarter 2026 revenue of $3.3 billion, a 5.1% decrease year-over-year, and a net loss of $24 million primarily due to $111 million in non-cash impairment charges. The company also announced it is suspending the strategic review and sales process for its Specialty segment to allow new leadership to conduct a comprehensive business assessment.
Term
Q3 2026
“LKQ remains a fundamentally strong enterprise, supported by its scale, leading positions across key markets, and global distribution platform. At the same time, our recent financial and operating performance has not reflected the strength of the business or met the standards we expect, particularly in Europe.”
John Mendel, Chairman of the Board of LKQ
“The third quarter was characterized by weakness in our Europe segment, driven by operational issues related to the ERP implementation in Germany and volume declines in the United Kingdom and Benelux. Specialty was modestly below plan. North America performed in line with expectations despite a softer demand environment.”
Leonardo DRS reported strong Q3 2026 results with revenue growing 11% to $1.1 billion and net earnings up 60% to $115 million. The company achieved record bookings of $1.6 billion and a record funded backlog of $5.6 billion, leading management to raise its full-year 2026 guidance for revenue and profitability.
Term
Q3 2026
“Leonardo DRS delivered a strong third quarter, with 11% organic revenue growth and profitability growing even faster. Bookings exceeded $1.6 billion, representing a 1.5x book-to-bill ratio — both our strongest since becoming a public company four years ago. These results reinforce a strategy that is working — investing ahead of demand, in both differentiated capability and capacity, to help our customers maintain overmatch and enable us to scale when the mission requires it. Our record funded backlog, together with improved visibility into the fourth quarter, gives us confidence to raise and narrow our full-year revenue and profitability outlook.”
WEC Energy Group reported Q3 2026 net income of $389.3 million, or $1.18 per share, driven by warmer-than-normal weather and capital plan execution. Based on strong performance, the company raised and narrowed its full-year 2026 earnings guidance to $5.60-$5.64 per share.
Term
Q3 2026
“Our strong results were driven by warmer-than-normal weather, execution of our capital plan and operating efficiency. Our continued focus on the fundamentals of our business is creating value for our customers and stockholders. We remain on track to deliver solid financial and operational performance in 2026.”
Carrier Global reported third quarter 2026 results with net sales of $6.3 billion, up 12% year-over-year, and organic sales growth of 15%. While the company reported a GAAP net loss of $2.6 billion due to a goodwill impairment charge, adjusted EPS rose 30% to $0.87, driven by strong demand in data centers and commercial HVAC.
Term
Q3 2026
“We delivered strong third quarter performance, with orders, sales and adjusted EPS all up between 15% and 35%, with very strong free cash flow. Organic orders were up ~35%, with data center orders up ~300%, resulting in over $8.5 billion of backlog, up 60% versus last year, reflecting continued strong demand for our differentiated solutions.”
EMCOR Group, Inc. reported significant growth for the nine months ended September 30, 2026, with revenues increasing to $15.32 billion from $12.47 billion in the prior year. Net income rose to $1.11 billion, driven by strong performance across segments, despite a $34.0 million impairment loss on identifiable intangible assets.
The filing details ongoing litigation matters for Altria Group, Inc., including product liability, health care cost recovery, and antitrust cases. Notable pending actions include international health care cost recovery suits in Canada and various class actions related to e-vapor products and 'Lights' cigarette branding.
TriNet Group reported third quarter 2026 financial results with total revenues of $1.2 billion, a 5% decrease year-over-year. While net income and worksite employee counts declined, the company noted that earnings exceeded its forecast and new sales returned to growth, leading management to expect full-year earnings at the top end of its guidance range.
Term
3 months
“We delivered solid third quarter results and made further progress against our strategic priorities. Earnings performance exceeded our forecast, customer retention improved, and new sales returned to year-over-year growth.”
Mike Simonds, TriNet’s President and CEO
“Our growth initiatives are gaining traction. Momentum within our broker channel is building, our investments in sales are driving improved performance in our important fall selling season, and we are strengthening our customer value proposition through investments in our service model and an expanding set of solutions, such as TriNet Leave powered by Cocoon, TriNet Recruit, and TriNet Spend. With these initiatives gaining traction, we believe TriNet is increasingly well-positioned to return to sustainable growth.”
Baxter International reported Q3 2026 financial results with sales of $2.98 billion, a 5% increase on both a reported and organic basis. The company achieved GAAP diluted EPS of $0.57 and raised its full-year 2026 financial outlook while completing a $600 million debt tender offer to accelerate deleveraging.
Term
Q3 2026
“We delivered a strong third quarter, with growth across all segments and divisions globally. We continue to make steady progress stabilizing the business, strengthening the balance sheet and driving continuous improvement. Our results reinforce our confidence in this direction as we build a stronger foundation for sustainable growth and long-term value creation.”
Stagwell Inc. reported Q3 2026 revenue of $816 million, a 10% year-over-year increase, driven by significant growth in its Digital Transformation and Marketing Cloud segments. The company raised its full-year 2026 guidance for Adjusted EBITDA and Adjusted EPS following record net new business of $168 million in the quarter.
Term
Q3 2026
“This is the biggest quarter in Stagwell’s history. It shows we are on track to become number one in marketing transformation. Software products, like our agentic Stagwell Machines, and the Digital Transformation segment are driving our business as we pivot from primarily marketing services to AI-powe”
Kymera Therapeutics reported collaboration revenue of $99.4 million for the nine months ended September 30, 2026, a significant increase from $36.3 million in the prior year. Despite this, the company recorded a net loss of $262.4$ million for the period due to rising research and development expenses, which reached $346.2 million.
CCC Intelligent Solutions reported third quarter 2026 revenue of $294.1 million, a 10% increase year-over-year, driven by strong adoption of its AI-related solutions. The company also highlighted its pending $6.1 billion acquisition by a consortium led by GTCR and Elliott Investment Management, which is expected to close in Q1 2027. GAAP net income improved significantly to $30.2 million compared to a net loss in the prior year period.
“CCC delivered strong third quarter results, with revenue growth of 10% and adjusted EBITDA margin of approximately 44%. Our performance reflects the durability of our business, the trust customers place in us, and the increasing role our platform plays in helping participants across the insurance economy operate more efficiently and achieve better outcomes.”
Githesh Ramamurthy, Chairman & CEO of CCC
“The pending transaction with GTCR and Elliott marks an exciting next chapter for CCC and our customers. Together, we expect to accelerate the AI and agentic capabilities our customers want from us, expand the network at the center of our platform, and make long-term investments in innovation that help customers navigate growing complexity across the claims lifecycle.”
Ligand Pharmaceuticals reported Q3 2026 financial results, highlighted by a 51% year-over-year increase in royalty revenue to $70.3 million, driven by the XOMA portfolio and commercial momentum of Filspari. The company raised its full-year 2026 adjusted diluted EPS guidance to a range of $9.50 to $9.75 while reaffirming its total revenue guidance.
Term
Q3 2026
“Ligand delivered another strong quarter, with royalty revenue growing 51% year-over-year, driven by contribution from the XOMA portfolio and continued commercial momentum across our key royalty assets, including Filspari.”
Laureate Education reported Q3 2026 financial results with revenue increasing 21% to $485.1 million and net income rising to $101.2 million. The company reaffirmed its full-year 2026 guidance and announced a $150 million increase to its share repurchase authorization.
Term
Q3 2026
“We are pleased to report strong new enrollment intakes in both of our markets. The primary intake in Mexico included a very successful launch of our new campus in Puebla, as well as further growth in existing campuses. During the secondary intake in Peru, we continued to leverage our fully online capabilities to meet growing demand for working adults as that market scales.”
Eilif Serck-Hanssen, President and Chief Executive Officer
West Bancorporation reported Q3 2026 net income of $11.6 million, an increase from $9.3 million in the prior year period, driven by margin expansion and expense discipline. The company also declared a quarterly dividend of $0.26 per share and reported pristine credit quality with zero nonaccrual loans.
Term
Q3 2026
“Our net income for the first nine months of 2026 has increased 32 percent compared to the first nine months of 2025. Our annualized return on average equity has improved to 16.18 percent for the first nine months of 2026, compared to 14.27 percent for the first nine months of 2025 and our annualized return on average assets has grown to 1.16 percent in the third quarter of 2026.”
David Nelson, President and Chief Executive Officer
“Our balance sheet remains exceptionally strong, supported by solid capital and liquidity levels. Credit quality remains pristine with no loans on nonaccrual status at September 30, 2026. Additionally, this marks our ninth consecutive quarter-end with no loans greater than 30 days past due.”
David Nelson, President and Chief Executive Officer
Laureate Education reported strong growth for the third quarter of 2026, with revenues increasing to $485.1 million from $400.2 million in the prior year period. Net income attributable to the company rose significantly to $101.2 million, driven by improved operating performance and favorable foreign currency exchange gains.
Bicycle Therapeutics reported collaboration revenue of $34.1 million for the quarter ended September 30, 2026, a significant increase from $11.7 million in the prior year. The company reduced its quarterly net loss to $9.3 million compared to $58.9 million in 2025, primarily driven by higher revenue and a decrease in research and development expenses following a strategic reprioritization.
West Bancorporation reported net income of $33.3 million for the first nine months of 2026, a significant increase from $25.1 million in the same period of 2025, driven primarily by higher net interest income. Total assets decreased to $3.89 billion as of September 30, 2026, compared to $4.14 billion at year-end 2025, largely due to a reduction in interest-earning deposits with banks.
Garrett Motion Inc. reported net sales of $930 million for the third quarter of 2026, a 3.1% increase compared to $902 million in the prior year. Net income rose to $97 million from $77 million, driven by higher gross profit and lower tax expenses, while the company continued its share repurchase program, spending $172 million in the first nine months of the year.
Blue Owl Capital reported its third quarter 2026 financial results, highlighting nearly $50 billion raised over the last twelve months and total assets under management of $330 billion. The company also declared a quarterly cash dividend of $0.23 per Class A share, payable on November 23, 2026.
Term
Q3 2026
“Blue Owl demonstrated durability, resilience and an acceleration of growth during the third quarter. Our strategies continue to generate excellent investment results, and we believe the nearly $50 billion we’ve raised over the last twelve months reflects ongoing investor support and conviction around our disciplined approach to investing.”
Doug Ostrover and Marc Lipschultz, Co-CEOs of Blue Owl
Life Time Group Holdings reported strong growth for the nine months ended September 30, 2026, with total revenue increasing to $2.55 billion from $2.25 billion in the prior year. Net income rose to $295.9 million, supported by a significant increase in center revenue and improved operating margins, while the company continued heavy investment in capital expenditures totaling $812.0 million.
Linde plc reported record third-quarter 2026 sales of $9.4 billion, up 9% year-over-year, driven by price attainment and volume growth in electronics and chemicals. Adjusted EPS rose 9% to $4.59, and the company generated strong operating cash flow of $3.2 billion. Management narrowed its full-year 2026 adjusted EPS guidance to $17.82 - $17.92, representing 8% to 9% growth.
Term
Q3 2026
“Linde’s financial performance continued to improve in the third quarter, with record sales of $9.4 billion and record EPS of $4.59, alongside strong operating cash flow of $3.2 billion. During the quarter we took further actions to improve productivity and strengthen performance across our businesses, while maintaining our goal to deliver industry-leading results.”
Sanjiv Lamba, Chief Executive Officer
“Customer proposal activity remains robust, particularly across electronics, supporting our confidence in continued backlog growth. Regardless of the economic environment, we remain focused on operational excellence, disciplined capital deployment and securing high-quality projects that will compound shareholder value over the long term.”
Axalta Coating Systems reported Q3 2026 financial results with net sales of $1.3 billion, up 2% year-over-year, driven by record performance in its Mobility segment. Net income was $95 million, impacted by $14 million in merger and acquisition-related expenses, while the company achieved its lowest-ever total net leverage of 2.1x.
Term
3 months
“Axalta delivered another quarter of revenue growth, strong cash generation and robust profitability despite a more challenging operating environment. We maintained Adjusted EBITDA margin above 20%, further strengthened our balance sheet and achieved record quarterly net sales in Mobility Coatings. As we look ahead, we remain focused on disciplined execution and are confident in the significant value creation opportunity associated with our proposed combination with AkzoNobel.”
Chris Villavarayan, Chief Executive Officer and President of Axalta
Myers Industries reported net sales of $171.3 million for the quarter ended September 30, 2026, an increase from $158.5 million in the prior year. However, the company realized a net loss of $0.87 million for the quarter, primarily driven by a $5.6 million loss from discontinued operations and a $3.5 million loss on debt extinguishment.
Kymera Therapeutics reported financial results for the third quarter ended September 30, 2026, and announced positive Phase 1 data for its IRF5 degrader, KT-579. The company remains well-capitalized with $1.6 billion in cash, providing a runway into 2029, and expects topline Phase 2b data for its STAT6 degrader, KT-621, by year-end 2026.
Term
Q3 2026
“Kymera’s recent progress reinforces the opportunity across our portfolio and our ability to help shape a new era of differentiated oral medicines in immunology. With KT-621 and KT-579, we are advancing complementary immunoregulatory mechanisms that target distinct drivers of disease, with significant potential to address unmet needs across the current treatment landscape.”
Nello Mainolfi, PhD, Founder, President and CEO, Kymera Therapeutics
“The positive results from the Phase 1 healthy volunteer trial of KT-579, which we reported today, demonstrate strong translation of its preclinical pharmacology into humans and highlight its potential to modulate multiple core inflammatory pathways through a single oral mechanism.”
Nello Mainolfi, PhD, Founder, President and CEO, Kymera Therapeutics